Form 4: Azenta Director Alan J. Malus Acquires 995 Shares in Board Appointment

Director Alan J. Malus acquired 995 shares of Azenta, Inc. common stock on November 6, 2024, as part of his appointment to the Board of Directors.

Summary

• Alan J. Malus, a director of Azenta, Inc., acquired 995 shares of common stock on November 6, 2024.
• The shares were granted as part of his appointment to the Board of Directors.
• The transaction was a direct acquisition, and no payment was made for the shares.
• The price of the shares at the time of the transaction was $46.52.

Sentiment

Score: 7

Explanation: The document reflects a standard corporate action, with no negative implications. The share grant is a positive sign of alignment between the director and the company.

Positives

• The acquisition of shares by a director demonstrates alignment of interests with shareholders.
• The grant of shares as part of a board appointment is a common practice.

Industry Context

This type of transaction is common when a new director joins a company's board, aligning their interests with the company's performance and shareholder value.

Comparison to Industry Standards

• Granting shares to new board members is a standard practice across the industry to incentivize directors and align their interests with shareholders.
• Many companies, such as Thermo Fisher Scientific and Danaher, also use equity grants as part of their director compensation packages.

Management Changes

Stakeholder Impact

• The share acquisition by a director can be viewed positively by shareholders as it aligns the director's interests with the company's performance.

Key Dates

Keywords

Azenta, Director, Share Acquisition, Board Appointment, Alan J. Malus, Equity